237 related articles for article (PubMed ID: 17519292)
1. Lubiprostone: a chloride channel activator for treatment of chronic constipation.
Ambizas EM; Ginzburg R
Ann Pharmacother; 2007 Jun; 41(6):957-64. PubMed ID: 17519292
[TBL] [Abstract][Full Text] [Related]
2. Lubiprostone: chloride channel activator for chronic constipation.
Rivkin A; Chagan L
Clin Ther; 2006 Dec; 28(12):2008-21. PubMed ID: 17296458
[TBL] [Abstract][Full Text] [Related]
3. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety.
Johanson JF; Ueno R
Aliment Pharmacol Ther; 2007 Jun; 25(11):1351-61. PubMed ID: 17509103
[TBL] [Abstract][Full Text] [Related]
4. Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation.
Crowell MD; Harris LA; DiBaise JK; Olden KW
Curr Opin Investig Drugs; 2007 Jan; 8(1):66-70. PubMed ID: 17263187
[TBL] [Abstract][Full Text] [Related]
5. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation.
Johanson JF; Morton D; Geenen J; Ueno R
Am J Gastroenterol; 2008 Jan; 103(1):170-7. PubMed ID: 17916109
[TBL] [Abstract][Full Text] [Related]
6. Lubiprostone for chronic idiopathic constipation and irritable bowel syndrome with constipation.
Saad R; Chey WD
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):497-508. PubMed ID: 19072397
[TBL] [Abstract][Full Text] [Related]
7. Lubiprostone: a new drug for the treatment of chronic idiopathic constipation.
Baker DE
Rev Gastroenterol Disord; 2007; 7(4):214-22. PubMed ID: 18192957
[TBL] [Abstract][Full Text] [Related]
8. Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.
Chamberlain SM; Rao SS
Expert Opin Drug Saf; 2012 Sep; 11(5):841-50. PubMed ID: 22834474
[TBL] [Abstract][Full Text] [Related]
9. Lubiprostone: a chloride channel activator.
Lacy BE; Levy LC
J Clin Gastroenterol; 2007 Apr; 41(4):345-51. PubMed ID: 17413599
[TBL] [Abstract][Full Text] [Related]
10. Lubiprostone.
McKeage K; Plosker GL; Siddiqui MA
Drugs; 2006; 66(6):873-9. PubMed ID: 16706562
[TBL] [Abstract][Full Text] [Related]
11. Lubiprostone (amitiza) for chronic constipation.
Med Lett Drugs Ther; 2006 Jun; 48(1236):47-8. PubMed ID: 16770297
[No Abstract] [Full Text] [Related]
12. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.
Camilleri M; Bharucha AE; Ueno R; Burton D; Thomforde GM; Baxter K; McKinzie S; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G942-7. PubMed ID: 16603730
[TBL] [Abstract][Full Text] [Related]
13. Lubiprostone.
Winpenny JP
IDrugs; 2005 May; 8(5):416-22. PubMed ID: 15883925
[TBL] [Abstract][Full Text] [Related]
14. Lubiprostone for constipation and irritable bowel syndrome with constipation.
Tuteja AK; Rao SS
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):727-33. PubMed ID: 19090733
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders.
Ginzburg R; Ambizas EM
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1091-7. PubMed ID: 18680443
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.
Johanson JF; Drossman DA; Panas R; Wahle A; Ueno R
Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656
[TBL] [Abstract][Full Text] [Related]
17. Lubiprostone for the treatment of opioid-induced bowel dysfunction.
Wong BS; Camilleri M
Expert Opin Pharmacother; 2011 Apr; 12(6):983-90. PubMed ID: 21385112
[TBL] [Abstract][Full Text] [Related]
18. Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.
Raschi E; De Ponti F
Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):293-305. PubMed ID: 24387275
[TBL] [Abstract][Full Text] [Related]
19. Lubiprostone for the treatment of functional constipation in children.
Hyman PE; Di Lorenzo C; Prestridge LL; Youssef NN; Ueno R
J Pediatr Gastroenterol Nutr; 2014 Mar; 58(3):283-91. PubMed ID: 24048162
[TBL] [Abstract][Full Text] [Related]
20. Lubiprostone: RU 0211, SPI 0211.
Drugs R D; 2005; 6(4):245-8. PubMed ID: 15991886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
